ClinicalTrials.Veeva

Menu

Evaluation of a New Invitation Procedure to the French Organized Colorectal Cancer Screening Program (KITCOLO22)

I

International Agency for Research on Cancer

Status

Active, not recruiting

Conditions

Colorectal Cancer

Treatments

Other: Sending of a prior notification to the new entrants of the national program
Other: Dispatch of the screening test along the invitation letter to the national colorectal cancer screening program

Study type

Interventional

Funder types

Other

Identifiers

NCT05589675
IEC/22-29

Details and patient eligibility

About

This is a randomized controlled trial comparing the effect on participation rates to colorectal cancer screening between an intervention arm (invitation letter to the screening program including a FIT test with or without prior notification) and a control arm with the standard of care (invitation letter to visit the GP who will deliver the FIT test).

Full description

The participation to the national screening program for colorectal cancer in France is low. In order to improve the performances of its organized program, the National Cancer Institute is planning to modify the invitation procedure. This is a pilot project and if an improvement in the program performances is reported, the invitation procedure may be scaled up.

Eligible individuals for colorectal cancer screening will be identified by the Regional Cancer Screening Coordinating Centre and randomized into the intervention or control arms. They will be followed for FIT test submission to the central laboratory (participation to screening). Those who did not send their test will receive reminder letters. Those who had a positive FIT test will be followed up for coloscopy referral, and result of the coloscopy. Comparison of the participation rates to screening program and to coloscopy among those with a positive FIT test will be compared between the two study arms.

Enrollment

64,500 patients

Sex

All

Ages

50 to 74 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Women and men aged 50 to 74 years old
  • Living in the study area (Departments of Ardennes, Meurthe-et-Moselle, and Moselle, France)
  • At moderate risk of colorectal cancer, i.e. eligible to the organised programme and receiving the first invitation of the screening round (not a reminder letter)

Exclusion criteria

  • Outside the target age (less than 50 years old, or 75 years and more)
  • Receiving the reminder letter
  • At high or very high risk of colorectal cancer

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

64,500 participants in 3 patient groups

Intervention arm
Experimental group
Description:
Invitation letter to the screening program with the FIT test
Treatment:
Other: Dispatch of the screening test along the invitation letter to the national colorectal cancer screening program
Intervention arm - sub study
Experimental group
Description:
Prior notification to the new entrants, followed by an invitation letter to the screening program with the FIT test
Treatment:
Other: Dispatch of the screening test along the invitation letter to the national colorectal cancer screening program
Other: Sending of a prior notification to the new entrants of the national program
Control arm
No Intervention group
Description:
Invitation letter to visit its own GP who will deliver the FIT test

Trial contacts and locations

3

Loading...

Central trial contact

Farida Selmouni, PhD; Catherine Sauvaget, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems